FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Accepts Few Labeling Changes for Propecia

FDA orders some Propecia labeling changes sought in a 2017 petition and denies most of the other changes sought.

FDA General

House Passes User Fee/FDA Amendments Bill

The U.S. House of Representatives votes 392 to 28 to pass the Food and Drug Amendments of 2022), which would reauthorize FDA user fee programs for pre...

Medical Devices

GE Ventilator Backup Battery Class 1 Recall

FDA sets a Class 1 designation on a recall of GE Healthcares ventilator batteries used in certain Carescape R860 Ventilators.

Federal Register

4 Advisory Committees Renewed for 2 Years

Federal Register notices: FDA renews the charters for four advisory committees for an additional two years.

Federal Register

Info Collection on New Animal Drug Submissions

Federal Register notice: FDA sends to OMB an information collection extension entitled New Animal Drug Applications and Veterinary Master Files.

Biologics

Superior Response in Covid Omicron Booster: Moderna

Moderna says its bivalent Covid vaccine booster specifically targeting the Omicron variant achieved superior antibody response against Omicron and cou...

Drug/Device User Interface MAPP

CDER issues a MAPP outlining the roles and responsibilities of the Office of Generic Drugs and Office of Surveillance and Epidemiology in assessing th...

Human Drugs

Legislation to Expand Affordable OTC Birth Control

Lawmakers introduce a bill to ensure access to over-the-counter oral birth control drugs.

Human Drugs

Apply Covid Lessons to Other Diseases: Drug Companie

Global Forum representatives from 12 major drug companies call for a Covid-19-like approach to therapies for other significant diseases and conditions...

Human Drugs

AAM Issues with FDA Quality Metrics Program

The Association for Accessible Medicines says it is concerned that FDA does not have statutory authority for its proposed quality metrics program.